Ticker

Analyst Price Targets — HQY

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
June 3, 2026 9:06 amRBC Capital$108.00$88.34StreetInsider RBC Capital Reiterates Outperform Rating on HealthEquity, Inc (HQY) Following Mgmt Meet
June 1, 2026 8:38 amWells Fargo$111.00$87.99StreetInsider HealthEquity, Inc (HQY) PT Raised to $111 at Citizens on Raised FY27-28 EPS Estimates
April 9, 2026 8:25 amSean DodgeBMO Capital$105.00$84.20TheFly HealthEquity upgraded to Outperform from Market Perform at BMO Capital
February 24, 2026 1:30 pmBMO Capital$85.00$74.78TheFly HealthEquity price target lowered to $85 from $100 at BMO Capital
February 19, 2026 6:37 pmJefferies$108.00$78.77TheFly HealthEquity price target lowered to $108 from $120 at Jefferies
February 18, 2026 10:09 amPeter WarendorfBarclays$110.00$74.36TheFly HealthEquity price target lowered to $110 from $118 at Barclays
February 17, 2026 12:17 pmUBS$110.00$73.88TheFly HealthEquity price target lowered to $110 from $130 at BTIG
February 17, 2026 10:43 amRaymond James$100.00$73.88TheFly HealthEquity price target lowered to $100 from $120 at Raymond James
January 9, 2026 10:43 amGoldman Sachs$89.00$98.51TheFly HealthEquity downgraded to Sell from Neutral at Goldman Sachs
January 8, 2026 12:42 pmScott SchoenhausKeyBanc$125.00$97.77TheFly HealthEquity price target raised to $125 from $120 at KeyBanc

Latest News for HQY

GDRX or HQY: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with GoodRx Holdings, Inc. (GDRX) and HealthEquity (HQY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Jul 8, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for HQY.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top